The European Medicines Agency approved two medicines to treat the multidrug-resistant form of tuberculosis, which afflicts about 1 in 20 people with the ailment, the world’s second-deadliest infectious disease.
The deal that helped one of the poorest nations raise $850 million and bond investors lock in rates three times higher than U.S. Treasuries is also spurring concern some of the money isn’t going where the buyers -- and one of the underwriters -- expected.
The $2.7 trillion U.S. health-care system lags behind other nations in improving its citizens’ health even as spending has doubled, increasing faster than any other industry over the past decade, researchers said.
Medtronic Inc.’s CoreValve replaced damaged aortic valves more safely than expected in patients who can’t tolerate traditional open-heart surgery, leading U.S. regulators to say it won’t need an advisory committee review.
This is a morbid column about some unexpected and encouraging news: Deep economic declines, such as the one we experienced in the U.S. a few years ago, probably lengthen life expectancy. This is exactly the opposite of what most people believe.